Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
- PMID: 28604701
- DOI: 10.1038/nm.4356
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
Erratum in
-
Erratum: Elimination of large tumors in mice by mRNA-encoded bispecific antibodies.Nat Med. 2017 Oct 6;23(10):1241. doi: 10.1038/nm1017-1241d. Nat Med. 2017. PMID: 28985209
Abstract
The potential of bispecific T cell-engaging antibodies is hindered by manufacturing challenges and short serum half-life. We circumvented these limitations by treating mice with in vitro-transcribed pharmacologically optimized, nucleoside-modified mRNA encoding the antibody. We achieved sustained endogenous synthesis of the antibody, which eliminated advanced tumors as effectively as the corresponding purified bispecific antibody. Because manufacturing of pharmaceutical mRNA is fast, this approach could accelerate the clinical development of novel bispecific antibodies.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources